U.S. FDA grants tentative approval to first generic injectable lenacapavir for HIV prevention
What the generic lenacapavir announcement means: FDA tentative approval, the US$40 annual injection price, starting medicines and access in Thailand.
อ่านภาษาไทย
Contents
The cover is a real photograph from Unitaid’s news announcement, credited and linked below the image. The consultation image in the article is an AI-generated illustration, not an actual service user.
On 2 November 2026, Unitaid reported that Dr. Reddy’s Laboratories had secured FDA tentative approval for the first generic injectable lenacapavir for HIV prevention. This is an access milestone, not an announcement of Thai clinic prices or opening dates. [1]
What does tentative approval mean?
FDA explains that a product with this status meets its approval requirements for quality, safety and effectiveness, but cannot yet receive U.S. marketing approval because of patents or exclusivity protecting the reference medicine. Certain tentatively approved medicines can be procured through international programmes such as PEPFAR. [3]
What does US$40 a year cover?
Unitaid’s September 2025 pricing announcement distinguishes the injectable medicine from the tablets used to start the regimen. US$40 should not be advertised as an all-inclusive patient price. [2]
| Item | Announced amount | How to read it |
|---|---|---|
| Injectable lenacapavir | US$40 per person per year | The injection medicine price under the access agreement |
| Oral initiation course | No more than US$17 | A separate starting course, not part of the annual injection figure |
| Testing, administration and follow-up | Ask the provider | This news does not set Thai service fees or free-service eligibility |
The figure is not US$40 per injection. Nor does it establish what an individual in Thailand will pay. Confirm costs and your eligibility before booking.
When could supply begin?
The latest announcement anticipates initial generic supplies reaching some countries before the end of 2026, followed by wider availability in 2027. These are conditional rollout expectations, not a simultaneous launch date for every country or clinic. [1]
What does this mean for Thailand?
Thailand appears in Gilead’s published voluntary-licence country list and among its priority registration markets. However, licence coverage does not confirm that this generic is already available in Thailand, or establish a local retail price or entitlement. [5]
For readers in Thailand, the practical questions are which product or programme a provider offers, when appointments open, who is eligible and which charges apply. A global access announcement and a local booking offer are not the same thing.
Long-acting PrEP still needs clinical care
WHO recommends twice-yearly injectable lenacapavir as an additional PrEP option within combination HIV prevention. It is not a vaccine or a replacement for every other option for everyone. [4]
The originator’s prescribing information requires HIV testing before starting and before subsequent injections. Undiagnosed HIV can lead to drug resistance. Starting the regimen also involves oral medicine; this is not an injection-only first visit or a stand-alone HIV treatment regimen. [6]
What should interested readers do next?
- Check programme announcements and ask the provider about eligibility, appointment dates and costs.
- Prepare questions about HIV testing, current medicines, follow-up and what to do if an injection is delayed or PrEP is stopped.
- If you already use PrEP, discuss continuity and alternatives with your care team rather than changing medicines because of a headline.
Follow LEN programme information in Thailand
View LEN programme information The programme team confirms terms and appointments. Reading this news does not book a visit or guarantee eligibility. The linked programme site may be in Thai.Read our HIV prevention and PrEP guide or HIV testing guide. For consultations and general bookings, see LINE Love2Test; a general PrEP booking is not confirmation of an appointment for generic lenacapavir.
Frequently asked questions
Can this generic now be sold in the United States?
Not under tentative approval alone. Patent or exclusivity conditions still prevent U.S. marketing approval.
Does US$40 include testing and services in Thailand?
No Thai all-inclusive price is established. It is the agreement's annual injection medicine figure, with oral initiation priced separately. Ask the provider about costs and eligibility.
Can people in Thailand receive the generic immediately?
This announcement does not confirm a Thai service opening date. Check the product, authorisation, conditions and appointments with the programme or clinic.
Do twice-yearly injections mean no further HIV testing?
No. HIV testing and follow-up remain part of care before starting and while using PrEP.
Sources and verification date
Checked on 3 November 2026. This is a news explainer, not a Thai regulatory notice or a personalised prescription.
- Unitaid — generic lenacapavir announcement, 2 November 2026
- Unitaid — US$40 agreement and oral initiation pricing
- U.S. FDA — tentative approval under PEPFAR
- WHO — injectable lenacapavir prevention recommendation
- Gilead — access strategy and licensed country list
- U.S. FDA — 2025 YEZTUGO originator label, for safety background
